Enlarged nuchal translucency and low serum protein concentrations as possible markers for Zellweger syndrome

Ultrasound in Obstetrics and Gynecology

Volumn 13, Issue 4, 1999, Pages 268-270

  De Graaf, I M ^a   Pajkrt, E ^a   Keessen, M ^b   Leschot, N J ^a   Bilardo, C M ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b Gooi Noord Hospital   (Netherlands)

Author keywords

First trimester; Nuchal translucency; Zellweger syndrome

Indexed keywords

CHORIONIC GONADOTROPIN; ESTRIOL; PLASMA PROTEIN;

ARTICLE; CASE REPORT; ESTRIOL BLOOD LEVEL; FETUS; FETUS ECHOGRAPHY; FIRST TRIMESTER PREGNANCY; HORMONE BLOOD LEVEL; HUMAN; KARYOTYPE; NECK MUSCLE; PERICARDIAL EFFUSION; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; ZELLWEGER SYNDROME;

ADULT; ALPHA-FETOPROTEINS; BIOLOGICAL MARKERS; CESAREAN SECTION; CHORIONIC GONADOTROPIN; ESTRIOL; FATAL OUTCOME; FEMALE; HUMANS; INFANT, NEWBORN; NECK; PREGNANCY; PREGNANCY OUTCOME; PREGNANCY TRIMESTER, FIRST; ULTRASONOGRAPHY, PRENATAL; ZELLWEGER SYNDROME;

EID: 0032997761     PISSN: 09607692     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1469-0705.1999.13040268.x     Document Type: Article

References (14)

1. 1. Bowen P, Lee CSN, Zellweger H, Lindenberg R. A familial syndrome of multiple congenital defects. Bull Johns Hopkins Hosp 1964;114:402-14
2. 2. Smith DW, Opitz JM, Inhorn SL. A syndrome of multiple developmental defects including polycystic kidneys and intrahepatic dysgenesis in two siblings. J Pediatr 1965;73:617-24
3. 3. Goldfischer S, Moore CL, Johnson AB, Spiro AJ, Valsamis MP, Wisniewski HK, Ritch RH, Norton WT, Rapin I, Gartner LM. Peroxisomal and mitochondrial defects in the cerebro-hepatorenal syndrome. Science 1973;179:62-4
4. 4. Theil AC, Schutgens RBH, Wanders RJA, Heymans HSA. Clinical recognition of patients affected by a peroxisomal disorder: a retrospective study in 40 patients. Eur J Pediatr 1992;151:117-20
5. 5. Bilardo CM, Pajkrt E, de Graaf IM, Mol BWJ, Bleter OP. Outcome of fetuses with an enlarged nuchal translucency and normal karyotype. Ultrasound Obstet Gynecol 1998;11: 401-6
6. 6. Pandya PP, Snijders RJM, Johnson SP, De Lourdes Brizot M, Nicolaides KH. Screening for fetal trisomies by maternal age and fetal nuchal translucency thickness at 10 to 14 weeks of gestation. Br J Obstet Gynaecol 1995;102:957-62
7. 7. Trauffer PM, Anderson CE, Johnson A, Heeger S, Morgan P, Wapner RJ. The natural history of cuploid pregnancies with first-trimester cystic hygromas. Am J Obstet Gynecol 1994; 170:1279-84
8. 8. Hyett J, Noble P, Sebire NJ, Snijders R, Nicolaides KH. Lethal congenital arthrogryposis presents with increased nuchal translucency at 10-14 weeks of gestation. Ultrasound Obstet Gynecol 1997;9:310-13
9. 9. Hösli IM, Tercanli S, Rehder H, Holzgreve W. Cystic hygroma as an early first-trimester ultrasound marker for recurrent Fryns' syndrome. Ultrasound Obstet Gynecol 1997;10:422-4
10. 10. Souka AP, Snijders RJ, Novakov A, Soares W, Nicolaides KH. Defects and syndromes in chromosomally normal fetuses with increased nuchal transluccncy thickness at 10-14 weeks of gestation. Ultrasound Obstet Gynecol 1998;11:391-100
11. 11. Pandya PP, Snijders RJ, Johnson A, Nicolaides KH. Natural history of trisomy 21 fetuses with increased nuchal translucency thickness. Ultrasound Obstet Gynecol 1995;5:381-3
12. 12. Pajkrt E, Bilardo CM, Van Lith JM, Mol BWJ, Bleker OP. Nuchal translucency measurement in normal fetuses. Obstet Gynecol 1995;86:994-7
13. 13. Hyett JA, Clayton PT, Moscoso G, Nicolaides KH. Increased first trimester nuchal translucency as a prenatal manifestation of Smith-Lemli-Opitz syndrome. Am J Med Genet 1995;58: 374-6
14. 14. Goodburn SF, Yates JRW, Raggart PR, Carr C, Ferguson-Smith ME, Kershaw AJ, Milton PJD, Ferguson-Smith MA. Second trimester maternal serum screening using alpha-teto-protein, human chorionic gonadotrophin and unconjugated oestriol: experience of a regional programme. Prenat Diagn 1994;14:391-402